Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Seaport Global Starts CVS Health at Buy With $110 Price Target

12/01/2021 | 06:17am EST


ę MT Newswires 2021
All news about CVS HEALTH CORPORATION
01/20CVS HEALTH CORPORATION : Ex-dividend day for
FA
01/19CVS Health, Uber to Provide Free Transportation Under New Health Zones Initiative
MT
01/19CVS Health and Uber Health Collaborate to Advance Health Equity in Communities Nationwi..
PR
01/19CVS Health and Uber Health Collaborate to Advance Health Equity in Communities Nationwi..
CI
01/18CVS HEALTH : How mobile health screenings increase access to care
PU
01/18CVS HEALTH : Breaking down health barriers by building affordable housing
PU
01/18CVS HEALTH : Bringing health home to seniors in Atlanta
PU
01/18CVS HEALTH : Alleviating food insecurity in Fresno, California
PU
01/18CVS HEALTH : Attacking food insecurity in Hartford, Connecticut
PU
01/14Walgreens, CVS shut some stores as Omicron variant complicates staffing issues
RE
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 291 B - -
Net income 2021 8 224 M - -
Net Debt 2021 47 932 M - -
P/E ratio 2021 17,3x
Yield 2021 1,93%
Capitalization 135 B 135 B -
EV / Sales 2021 0,63x
EV / Sales 2022 0,57x
Nbr of Employees 256 500
Free-Float -
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 103,45 $
Average target price 114,26 $
Spread / Average Target 10,4%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President